活血化瘀方治疗子宫肌瘤临床观察  

Promoting Blood Circulation and Removing Blood Stasis Prescription in the Treatment of Uterine Fibroids

作  者:林瑛[1] LIN Ying(Department of Gynecology,Xinfeng Hospital of Traditional Chinese Medicine,Jiangxi Province,Xinfeng 341600,China)

机构地区:[1]江西省信丰县中医院妇科,江西信丰341600

出  处:《中国中医药现代远程教育》2025年第3期126-128,共3页Chinese Medicine Modern Distance Education of China

摘  要:目的 观察活血化瘀方治疗子宫肌瘤瘀血积结证的临床效果。方法 选择2021年1月—2023年1月江西省信丰县中医院收治的子宫肌瘤瘀血积结证患者68例,以随机数字表法分为对照组和试验组,各34例。对照组采用米非司酮常规治疗,试验组采用米非司酮联合活血化瘀方治疗,比较两组临床效果和性激素水平[促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E_2)]。结果 试验组临床总有效率为88.24%(30/34),高于对照组的76.47%(26/34),差异有统计学意义(P<0.05)。治疗后,试验组FSH、LH、E_2水平均低于对照组,差异有统计学意义(P<0.05)。结论 活血化瘀方治疗子宫肌瘤瘀血积结证,临床效果显著,值得推广。Objective To observe the clinical effect of promoting blood circulation and removing blood stasis prescription in treating uterine fibroids with blood stasis syndrome.Methods Sixty-eight patients with uterine fibroids with blood stasis syndrome admited to Xinfeng Hospital of Traditional Chinese Medicine from January 2021 to January 2023 were randomly divided into control group and experimental group,with 34 cases in each group.The control group was treated with mifepristone,and the experimental group was treated with mifepristone combined with promoting blood circulation and removing blood stasis prescription.The clinical efficacy and sex hormone levels(follicle-stimulating hormone,luteinizing hormone,estradiol)were compared between the two groups.Results The total clinical effective rate of the experimental group was 88.24%(30/34),which was higher than that of the control group(76.47%,26/34),and the difference was statistically significant(P<0.05).After treatment,the levels of FSH,LH and E,in experimental group were beter than those in control group,and the difference was statistically significant(P<0.05).Conclusion Promoting blood circeulation and removing blood stasis prescription in treating uterine fibroids with blood stasis syndrome is significant,and it is worth popularizing.

关 键 词:石瘕 子宫肌瘤 活血化瘀法 中医药疗法 

分 类 号:R73[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象